Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government

Health Services Research & Development

Veterans Crisis Line Badge
Go to the ORD website
Go to the QUERI website

Citations Database Search Results

Download these results to MS Excel

271 records found for:
Title = COPD
Year =

  1. Leitao Filho FS, Mattman A, Schellenberg R, Criner GJ, Woodruff P, Lazarus SC, Albert RK, Connett J, Han MK, Gay SE, Martinez FJ, Fuhlbrigge AL, Stoller JK, MacIntyre NR, Casaburi R, Diaz P, Panos RJ, Cooper JA, Bailey WC, LaFon DC, Sciurba FC, Kanner RE, Yusen RD, Au DH, Pike KC, Fan VS, Leung JM, Paul Man SF, Aaron SD, Reed RM, Sin DD. Serum IgG Levels and Risk of COPD Hospitalization: A Pooled Meta-analysis. Chest. 2020 May 19.
  2. Keller T, Spece LJ, Donovan LM, Udris E, Coggeshall SS, Griffith M, Bryant AD, Casaburi R, Cooper JA, Criner GJ, Diaz PT, Fuhlbrigge AL, Gay SE, Kanner RE, Martinez FJ, Panos RJ, Shade D, Sternberg A, Stibolt T, Stoller JK, Tonascia J, Wise R, Yusen RD, Au DH, Feemster LC. Association of Guideline-Recommended COPD Inhaler Regimens With Mortality, Respiratory Exacerbations, and Quality of Life: A Secondary Analysis of the Long-Term Oxygen Treatment Trial. Chest. 2020 Apr 9.
  3. Akgün KM, Sigel K, Cheung KH, Kidwai-Khan F, Bryant AK, Brandt C, Justice A, Crothers K. Extracting lung function measurements to enhance phenotyping of chronic obstructive pulmonary disease (COPD) in an electronic health record using automated tools. PLoS ONE. 2020 Jan 16; 15(1):e0227730.
  4. Miake-Lye IM. Capsule Commentary on Stryczek et. al., De-implementing Inhaled Corticosteroids to Improve Care and Safety in COPD Treatment: Primary Care Providers' Perspectives. Journal of general internal medicine. 2020 Jan 1; 35(1):398.
  5. Barjaktarevic IZ, Buhr RG, Wang X, Hu S, Couper D, Anderson W, Kanner RE, Paine Iii R, Bhatt SP, Bhakta NR, Arjomandi M, Kaner RJ, Pirozzi CS, Curtis JL, O'Neal WK, Woodruff PG, Han MK, Martinez FJ, Hansel N, Wells JM, Ortega VE, Hoffman EA, Doerschuk CM, Kim V, Dransfield MT, Drummond MB, Bowler R, Criner G, Christenson SA, Ronish B, Peters SP, Krishnan JA, Tashkin DP, Cooper CB, NHLBI SubPopulations and InteRmediate Outcome Measures In COPD Study (SPIROMICS). Clinical Significance of Bronchodilator Responsiveness Evaluated by Forced Vital Capacity in COPD: SPIROMICS Cohort Analysis. International journal of chronic obstructive pulmonary disease. 2019 Dec 20; 14:2927-2938.
  6. Griffith MF, Feemster LC, Zeliadt SB, Donovan LM, Spece LJ, Udris EM, Au DH. Overuse and Misuse of Inhaled Corticosteroids Among Veterans with COPD: a Cross-sectional Study Evaluating Targets for De-implementation. Journal of general internal medicine. 2020 Mar 1; 35(3):679-686.
  7. Dransfield MT, Voelker H, Bhatt SP, Brenner K, Casaburi R, Come CE, Cooper JAD, Criner GJ, Curtis JL, Han MK, Hatipoglu U, Helgeson ES, Jain VV, Kalhan R, Kaminsky D, Kaner R, Kunisaki KM, Lambert AA, Lammi MR, Lindberg S, Make BJ, Martinez FJ, McEvoy C, Panos RJ, Reed RM, Scanlon PD, Sciurba FC, Smith A, Sriram PS, Stringer WW, Weingarten JA, Wells JM, Westfall E, Lazarus SC, Connett JE, BLOCK COPD Trial Group. Metoprolol for the Prevention of Acute Exacerbations of COPD. The New England journal of medicine. 2019 Dec 12; 381(24):2304-2314.
  8. Wan ES, Goldstein RL, Fan VS, Nguyen HQ, Hart JE, Garshick E, Orr EH, DeVivo I, Moy ML. Telomere length in COPD: Relationships with physical activity, exercise capacity, and acute exacerbations. PLoS ONE. 2019 Oct 17; 14(10):e0223891.
  9. Rinne ST, Lindenauer PK, Au DH. Unexpected Harm From an Intensive COPD Intervention. JAMA. 2019 Oct 8; 322(14):1357-1359.
  10. Arjomandi M, Zeng S, Barjaktarevic I, Barr RG, Bleecker ER, Bowler RP, Buhr RG, Criner GJ, Comellas AP, Cooper CB, Couper DJ, Curtis JL, Dransfield MT, Han MK, Hansel NN, Hoffman EA, Kaner RJ, Kanner RE, Krishnan JA, Paine R, Peters SP, Rennard SI, Woodruff PG, SPIROMICS Investigators. Radiographic lung volumes predict progression to COPD in smokers with preserved spirometry in SPIROMICS. The European respiratory journal. 2019 Oct 1; 54(4).
  11. Hoesterey D, Das N, Janssens W, Buhr RG, Martinez FJ, Cooper CB, Tashkin DP, Barjaktarevic I. Spirometric indices of early airflow impairment in individuals at risk of developing COPD: Spirometry beyond FEV/FVC. Respiratory medicine. 2019 Sep 1; 156:58-68.
  12. Stryczek K, Lea C, Gillespie C, Sayre G, Wanner S, Rinne ST, Wiener RS, Feemster L, Udris E, Au DH, Helfrich CD. De-implementing Inhaled Corticosteroids to Improve Care and Safety in COPD Treatment: Primary Care Providers' Perspectives. Journal of general internal medicine. 2020 Jan 1; 35(1):51-56.
  13. Rinne ST, Resnick K, Wiener RS, Simon SR, Elwy AR. VA Provider Perspectives on Coordinating COPD Care Across Health Systems. Journal of general internal medicine. 2019 May 1; 34(Suppl 1):37-42.
  14. Robinson SA, Shimada SL, Quigley KS, Moy ML. A web-based physical activity intervention benefits persons with low self-efficacy in COPD: results from a randomized controlled trial. Journal of behavioral medicine. 2019 Dec 1; 42(6):1082-1090.
  15. Rinne ST, Lindenauer PK, Au DH. Intensive Intervention to Improve Outcomes for Patients With COPD. JAMA. 2018 Dec 11; 320(22):2322-2324.
  16. Lareau S, Moseson E, Slatore CG. Exacerbation of COPD. American journal of respiratory and critical care medicine. 2018 Dec 1; 198(11):P21-P22.
  17. Barjaktarevic I, Kaner R, Buhr RG, Cooper CB. Bronchodilator responsiveness or reversibility in asthma and COPD - a need for clarity. International journal of chronic obstructive pulmonary disease. 2018 Oct 23; 13:3511-3513.
  18. Spece LJ, Donovan LM, Griffith MF, Collins MP, Feemster LC, Au DH. Quality of Care Delivered to Veterans with COPD Exacerbation and the Association with 30-Day Readmission and Death. COPD. 2018 Oct 1; 15(5):489-495.
  19. Zeidler MR, Martin JL, Kleerup EC, Schneider H, Mitchell MN, Hansel NN, Sundar K, Schotland H, Basner RC, Wells JM, Krishnan JA, Criner GJ, Cristenson S, Krachman S, Badr MS, SPIROMICS Research Group. Sleep disruption as a predictor of quality of life among patients in the subpopulations and intermediate outcome measures in COPD study (SPIROMICS). Sleep. 2018 May 1; 41(5).
  20. Magzamen S, Oron AP, Locke ER, Fan VS. Association of ambient pollution with inhaler use among patients with COPD: a panel study. Occupational and Environmental Medicine. 2018 May 1; 75(5):382-388.
  21. Lee J, Nguyen HQ, Jarrett ME, Mitchell PH, Pike KC, Fan VS. Effect of symptoms on physical performance in COPD. Heart & lung : the journal of critical care. 2018 Mar 1; 47(2):149-156.
  22. Thakur ER, Sansgiry S, Petersen NJ, Stanley M, Kunik ME, Naik AD, Cully JA. Cognitive and Perceptual Factors, Not Disease Severity, Are Linked with Anxiety in COPD: Results from a Cross-Sectional Study. International Journal of Behavioral Medicine. 2018 Feb 1; 25(1):74-84.
  23. Helfrich CD, Stryczek K. De-implementing inhaled corticosteroids to improve quality and safety for patients with mild-to-moderate COPD: Mixed-methods findings of primary-care providers' perspectives. QUERI Implementation Network Series [Cyberseminar]. HSR&D. 2017 Dec 7.
  24. Rinne ST, Graves MC, Bastian LA, Lindenauer PK, Wong ES, Hebert PL, Liu CF. Association between length of stay and readmission for COPD. The American journal of managed care. 2017 Aug 1; 23(8):e253-e258.
  25. Hansel NN, Paulin LM, Gassett AJ, Peng RD, Alexis N, Fan VS, Bleecker E, Bowler R, Comellas AP, Dransfield M, Han MK, Kim V, Krishnan JA, Pirozzi C, Cooper CB, Martinez F, Woodruff PG, Breysse PJ, Barr RG, Kaufman JD. Design of the Subpopulations and Intermediate Outcome Measures in COPD (SPIROMICS) AIR Study. BMJ open respiratory research. 2017 May 18; 4(1):e000186.
  26. Ratcliff CG, Barrera TL, Petersen NJ, Sansgiry S, Kauth MR, Kunik ME, Stanley MA, Cully JA. Recognition of anxiety, depression, and PTSD in patients with COPD and CHF: Who gets missed? General hospital psychiatry. 2017 Jul 1; 47:61-67.
  27. Reinke LF, Feemster LC, McDowell J, Gunnink E, Tartaglione EV, Udris E, Curtis JR, Au DH. The long term impact of an end-of-life communication intervention among veterans with COPD. Heart & lung : the journal of critical care. 2017 Jan 1; 46(1):30-34.
  28. Melzer AC, Ghassemieh BJ, Gillespie SE, Lindenauer PK, McBurnie MA, Mularski RA, Naureckas ET, Vollmer WM, Au DH. Patient characteristics associated with poor inhaler technique among a cohort of patients with COPD. Respiratory medicine. 2017 Feb 1; 123:124-130.
  29. Nguyen HQ, Herting JR, Pike KC, Gharib SA, Matute-Bello G, Borson S, Kohen R, Adams SG, Fan VS. Symptom profiles and inflammatory markers in moderate to severe COPD. BMC pulmonary medicine. 2016 Dec 3; 16(1):173.
  30. Long-Term Oxygen Treatment Trial Research Group, Albert RK, Au DH, Blackford AL, Casaburi R, Cooper JA, Criner GJ, Diaz P, Fuhlbrigge AL, Gay SE, Kanner RE, MacIntyre N, Martinez FJ, Panos RJ, Piantadosi S, Sciurba F, Shade D, Stibolt T, Stoller JK, Wise R, Yusen RD, Tonascia J, Sternberg AL, Bailey W. A Randomized Trial of Long-Term Oxygen for COPD with Moderate Desaturation. The New England journal of medicine. 2016 Oct 27; 375(17):1617-1627.
  31. Fan VS. Video to Home Inhaler Training for Rural Patients with COPD or Asthma. Paper presented at: VA Rural Health State of the Science Conference; 2016 Sep 12; Washington, DC.
  32. Fan VS, Gylys-Colwell I, Locke E, Sumino K, Nguyen HQ, Thomas RM, Magzamen S. Overuse of short-acting beta-agonist bronchodilators in COPD during periods of clinical stability. Respiratory medicine. 2016 Jul 1; 116:100-6.
  33. Han MK, Martinez CH, Au DH, Bourbeau J, Boyd CM, Branson R, Criner GJ, Kalhan R, Kallstrom TJ, King A, Krishnan JA, Lareau SC, Lee TA, Lindell K, Mannino DM, Martinez FJ, Meldrum C, Press VG, Thomashow B, Tycon L, Sullivan JL, Walsh J, Wilson KC, Wright J, Yawn B, Zueger PM, Bhatt SP, Dransfield MT. Meeting the challenge of COPD care delivery in the USA: a multiprovider perspective. The lancet. Respiratory medicine. 2016 Jun 1; 4(6):473-526.
  34. Liu C, Wong ES. Organizational Factors Associated with Length of Stay for Veterans with COPD. Paper presented at: American Thoracic Society Annual International Conference; 2016 Jun 1; San Francisco, CA.
  35. Liu C, Wong ES. Organizational Factors Associated with Length of Stay for Veterans with COPD. Poster session presented at: AcademyHealth Annual Research Meeting; 2016 Jun 1; Boston, MA.
  36. Wong ES, Hebert PL, Liu C. The Relationships between Resource Utilization in an Index Admission and Readmission and Post-discharge Costs for Patients with COPD. Poster session presented at: AcademyHealth Annual Research Meeting; 2016 Jun 1; Boston, MA.
  37. Fan VS. A Structural Equation Modeling Analysis of the Relationships Between Symptoms and Physical Performance in Patients with COPD. Paper presented at: American Thoracic Society Annual International Conference; 2016 May 16; San Francisco, CA.
  38. Fan VS. The impact of social support on changes in physical activity over 2-years in patients with COPD. Poster session presented at: American Thoracic Society Annual International Conference; 2016 May 16; San Francisco, CA.
  39. Rinne ST, Liu C. Gender Differences in Appropriate Treatment for COPD. Paper presented at: American Thoracic Society Annual International Conference; 2016 May 1; San Francisco, CA.
  40. Schure MB, Borson S, Nguyen HQ, Trittschuh EH, Thielke SM, Pike KC, Adams SG, Fan VS. Associations of cognition with physical functioning and health-related quality of life among COPD patients. Respiratory medicine. 2016 May 1; 114:46-52.
  41. Effing TW, Vercoulen JH, Bourbeau J, Trappenburg J, Lenferink A, Cafarella P, Coultas D, Meek P, van der Valk P, Bischoff EW, Bucknall C, Dewan NA, Early F, Fan V, Frith P, Janssen DJ, Mitchell K, Morgan M, Nici L, Patel I, Walters H, Rice KL, Singh S, Zuwallack R, Benzo R, Goldstein R, Partridge MR, van der Palen J. Definition of a COPD self-management intervention: International Expert Group consensus. European Respiratory Journal. 2016 Jul 1; 48(1):46-54.
  42. Melzer AC, Feemster LC, Collins MP, Au DH. Utilization and effectiveness of pharmacotherapy for tobacco use following admission for exacerbation of COPD. Journal of hospital medicine. 2016 Apr 1; 11(4):257-63.
  43. Ratcliff CG, Barrera T, Petersen NJ, Sansgiry S, Kauth M, Naik AD, Sorocco K, Cully J. Mental Health Diagnoses in the Medical Records of Patients with COPD and CHF: Who Gets Missed? Poster session presented at: American Psychosomatic Society Annual Scientific Meeting; 2016 Mar 12; Denver, CO.
  44. Fan VS, Gharib SA, Martin TR, Wurfel MM. COPD disease severity and innate immune response to pathogen-associated molecular patterns. International journal of chronic obstructive pulmonary disease. 2016 Mar 4; 11:467-77.
  45. Melzer AC, Feemster LC, Collins MP, Au DH. Predictors of Pharmacotherapy for Tobacco Use Among Veterans Admitted for COPD: The Role of Disparities and Tobacco Control Processes. Journal of general internal medicine. 2016 Jun 1; 31(6):623-9.
  46. Nguyen HQ, Bailey A, Coleman KJ, Desai S, Fan VS, Gould MK, Maddock L, Miller K, Towner W, Xiang AH, Moy ML. Patient-centered physical activity coaching in COPD (Walk On!): A study protocol for a pragmatic randomized controlled trial. Contemporary clinical trials. 2016 Jan 1; 46:18-29.
  47. Au DH. Weighing Heavy on COPD: Complex Relationship Between Weight, Symptoms, and COPD. Paper presented at: University of Illinois Department of Medicine Grand Rounds; 2015 Nov 17; Champaign, IL.
  48. Attia EF, McGinnis KA, Feemster LC, Akgün KM, Butt AA, Graber CJ, Fine MJ, Goetz MB, Rodriguez-Barradas MC, Pisani MA, Tindle HA, Brown ST, Soo Hoo GW, Rimland D, Gibert CL, Huang L, Freiberg MS, Hough CL, Crothers K. Association of COPD With Risk for Pulmonary Infections Requiring Hospitalization in HIV-Infected Veterans. Journal of acquired immune deficiency syndromes (1999). 2015 Nov 1; 70(3):280-8.
  49. Breland JY, Hundt NE, Barrera TL, Mignogna J, Petersen NJ, Stanley MA, Cully JA. Identification of Anxiety Symptom Clusters in Patients with COPD: Implications for Assessment and Treatment. International Journal of Behavioral Medicine. 2015 Oct 1; 22(5):590-6.
  50. Rinne ST, Liu CF, Feemster LC, Collins BF, Bryson CL, O'Riordan TG, Au DH. Thiazolidinediones are associated with a reduced risk of COPD exacerbations. International journal of chronic obstructive pulmonary disease. 2015 Aug 10; 10:1591-7.
  51. Celli BR, Decramer M, Wedzicha JA, Wilson KC, Agustí AA, Criner GJ, MacNee W, Make BJ, Rennard SI, Stockley RA, Vogelmeier C, Anzueto A, Au DH, Barnes PJ, Burgel PR, Calverley PM, Casanova C, Clini EM, Cooper CB, Coxson HO, Dusser DJ, Fabbri LM, Fahy B, Ferguson GT, Fisher A, Fletcher MJ, Hayot M, Hurst JR, Jones PW, Mahler DA, Maltais F, Mannino DM, Martinez FJ, Miravitlles M, Meek PM, Papi A, Rabe KF, Roche N, Sciurba FC, Sethi S, Siafakas N, Sin DD, Soriano JB, Stoller JK, Tashkin DP, Troosters T, Verleden GM, Verschakelen J, Vestbo J, Walsh JW, Washko GR, Wise RA, Wouters EF, ZuWallack RL, ATS/ERS Task Force for COPD Research. An official American Thoracic Society/European Respiratory Society statement: research questions in COPD. European respiratory review : an official journal of the European Respiratory Society. 2015 Jun 1; 24(136):159-72.
  52. Au DH, Berger D, Carvalho P, Collins MP, Goodman R, Gunnink E, McDowell J, Moss B, Nelson KM, Plumley R, Reinke LF, Weppner W, Woo D, Feemster LM. COPD Hospital Readmissions Penalties: Do Patients Discharged with COPD diagnoses have COPD? Poster session presented at: American Thoracic Society Annual International Conference; 2015 May 20; Denver, CO.
  53. Melzer AC, Au DH. Effectiveness of Post-Discharge Smoking Cessation Management Following Exacerbation of COPD. Paper presented at: American Thoracic Society Annual International Conference; 2015 May 20; Denver, CO.
  54. Rinne S, Wong ES, Hebert PL, Au DH, Concato J, Liu C. Average Facility Length of Stay for COPD Hospitalization is Not Associated with Readmission or Mortality. Poster session presented at: American Thoracic Society Annual International Conference; 2015 May 20; Denver, CO.
  55. Rinne S, Wong ES, Hebert PL, Au DH, Justice AC, Liu C. Organizational Factors and Risk of Readmission Among Patients Hospitalized for COPD. Paper presented at: American Thoracic Society Annual International Conference; 2015 May 19; Denver, CO.
  56. Fleehart MS, Nguyen HQ, Fan VS, Hunter C, Chen Z, Reinke LF. The Effect of Psychosocial Behavioral Therapy for Patients with COPD and Depression. Poster session presented at: American Thoracic Society Annual International Conference; 2015 May 18; Denver, CO.
  57. Sumino K, Locke E, Magzamen S, Thomas R, Gylys-Colwell I, Nguyen HQ, Fan VS. Use of a remote inhaler monitor device to measure change in inhaler use with COPD exacerbations. Poster session presented at: American Thoracic Society Annual International Conference; 2015 May 10; Denver, CO.
  58. Celli BR, Decramer M, Wedzicha JA, Wilson KC, Agustí A, Criner GJ, MacNee W, Make BJ, Rennard SI, Stockley RA, Vogelmeier C, Anzueto A, Au DH, Barnes PJ, Burgel PR, Calverley PM, Casanova C, Clini EM, Cooper CB, Coxson HO, Dusser DJ, Fabbri LM, Fahy B, Ferguson GT, Fisher A, Fletcher MJ, Hayot M, Hurst JR, Jones PW, Mahler DA, Maltais F, Mannino DM, Martinez FJ, Miravitlles M, Meek PM, Papi A, Rabe KF, Roche N, Sciurba FC, Sethi S, Siafakas N, Sin DD, Soriano JB, Stoller JK, Tashkin DP, Troosters T, Verleden GM, Verschakelen J, Vestbo J, Walsh JW, Washko GR, Wise RA, Wouters EF, ZuWallack RL, ATS/ERS Task Force for COPD Research. An official American Thoracic Society/European Respiratory Society statement: research questions in COPD. European Respiratory Journal. 2015 Apr 1; 45(4):879-905.
  59. Collins BF, Feemster LC, Rinne ST, Au DH. Factors predictive of airflow obstruction among veterans with presumed empirical diagnosis and treatment of COPD. Chest. 2015 Feb 1; 147(2):369-76.
  60. Fleehart S, Fan VS, Nguyen HQ, Lee J, Kohen R, Herting JR, Matute-Bello G, Adams SG, Pagalilauan G, Borson S. Prevalence and correlates of suicide ideation in patients with COPD: a mixed methods study. International journal of chronic obstructive pulmonary disease. 2014 Dec 4; 10:1321-9.
  61. Collins BF, Ramenofsky D, Au DH, Ma J, Uman JE, Feemster LC. The association of weight with the detection of airflow obstruction and inhaled treatment among patients with a clinical diagnosis of COPD. Chest. 2014 Dec 1; 146(6):1513-20.
  62. Au DH. Co-morbidities – common pathophysiology and management challenges in COPD. Introduction to care model. Paper presented at: Chronic Obstructive Pulmonary Disease 9 Conference; 2014 Jun 25; Birmingham, England.
  63. Rinne S, Liu C, Wong ES, Hebert PL, Au DH. Differences in Organizational Structure to Support Patients with CHF and COPD. Poster session presented at: AcademyHealth Annual Research Meeting; 2014 Jun 10; San Diego, CA.
  64. Danilack VA, Weston NA, Richardson CR, Mori DL, Moy ML. Reasons persons with COPD do not walk and relationship with daily step count. COPD. 2014 Jun 1; 11(3):290-9.
  65. Au DH. COPD Treatment, Volume Reduction Surgery, and Supplemental Oxygen. Presented at: American Thoracic Society Annual International Conference; 2014 May 16; San Diego, CA.
  66. Au DH. Hospital Readmissions for COPD: Is this a Valid Measure of Quality? Paper presented at: American Thoracic Society Annual International Conference; 2014 May 16; San Diego, CA.
  67. Chen Z, Fan VS, Nguyen H. Association Between Social Support and Physical Activity In Patients With COPD. Paper presented at: American Thoracic Society Annual International Conference; 2014 May 16; San Diego, CA.
  68. Collins BF, Feemster LC, Uman J, Au DH. Obesity And Smoking Status: COPD Patient Ratings Of Quality Of Care. Poster session presented at: American Thoracic Society Annual International Conference; 2014 May 16; San Diego, CA.
  69. Joo MJ, Au DH, Fitzgibbon M, Bunyan A, Vinicky M, Lee TA. Comparative Effectiveness of a COPD Assessment And Management Bundle Versus Usual Care: Baseline Characteristics. Poster session presented at: American Thoracic Society Annual International Conference; 2014 May 16; San Diego, CA.
  70. Norweg AM, Pickard S, Rolle AJ, Au DH, Carson SS, Collins EG, DeLisa J, Lindenauer PK, McBurnie MA, Mulareski RA, Naureckas E, Vollmer WM, Wang E, Krishnan JA. Anxiety Moderates the Association Of Dyspnea With Physical Function In People With COPD. Poster session presented at: American Thoracic Society Annual International Conference; 2014 May 16; San Diego, CA.
  71. Fan VS. Advances in Research for COPD. Presented at: American Lung Association Annual Respiratory Rally; 2014 May 3; Seattle, WA.
  72. Fan VS. COPD and Depression. Paper presented at: Northwest Association of Cardiovascular and Pulmonary Rehabilitation Annual Conference; 2014 Apr 26; Tacoma, WA.
  73. Breland JY, Hundt NE, Barrera TL, Mignogna J, Petersen NJ, Stanley MA, Cully JA. Distinguishing Between COPD & Anxiety: Factor Structure of the Beck Anxiety Inventory. Poster session presented at: Society of Behavioral Medicine Annual Meeting and Scientific Sessions; 2014 Apr 23; Philadelphia, PA.
  74. Richardson CR. An Internet-Mediated Walking Program for Veterans with COPD. Paper presented at: Society of Behavioral Medicine Annual Meeting and Scientific Sessions; 2014 Apr 23; Philadelphia, PA.
  75. Martinez CH, St Jean BL, Plauschinat CA, Rogers B, Beresford J, Martinez FJ, Richardson CR, Han MK. Internet access and use by COPD patients in the National Emphysema/COPD Association Survey. BMC pulmonary medicine. 2014 Apr 22; 14(1):66.
  76. Au DH. Are we delivering high quality care for patients with COPD? Paper presented at: MetroHealth System Department of Medicine Grand Rounds; 2014 Apr 1; Cleveland, OH.
  77. Au DH. Patient Adherence to Pharmacological Treatments for COPD Should We Care? Paper presented at: MetroHealth System Department of Medicine Grand Rounds; 2014 Apr 1; Cleveland, OH.
  78. Lareau S, Moseson E, Slatore CG. Exacerbation of COPD. American journal of respiratory and critical care medicine. 2014 Mar 15; 189(6):P11-2.
  79. Kumar N, Liang D, Comellas A, Chu AD, Abrams T. Satellite-based PM concentrations and their application to COPD in Cleveland, OH. Journal of exposure science & environmental epidemiology. 2013 Nov 1; 23(6):637-46.
  80. Yeatts KB, Lippmann SJ, Waller AE, Hassmiller Lich K, Travers D, Weinberger M, Donohue JF. Population-based burden of COPD-related visits in the ED: return ED visits, hospital admissions, and comorbidity risks. Chest. 2013 Sep 1; 144(3):784-93.
  81. Joo MJ, Sharp LK, Au DH, Lee TA, Fitzgibbon ML. Use of spirometry in the diagnosis of COPD: a qualitative study in primary care. COPD. 2013 Aug 1; 10(4):444-9.
  82. Bjerk SM, Edgington BD, Rector TS, Kunisaki KM. Supplemental vitamin D and physical performance in COPD: a pilot randomized trial. International journal of chronic obstructive pulmonary disease. 2013 Jul 11; 8:97-104.
  83. Nguyen HQ, Fan VS, Herting J, Lee J, Fu M, Chen Z, Borson S, Kohen R, Matute-Bello G, Pagalilauan G, Adams SG. Patients with COPD with higher levels of anxiety are more physically active. Chest. 2013 Jul 1; 144(1):145-51.
  84. Park SK, Richardson CR, Holleman RG, Larson JL. Physical activity in people with COPD, using the National Health and Nutrition Evaluation Survey dataset (2003-2006). Heart & lung : the journal of critical care. 2013 Jul 1; 42(4):235-40.
  85. Joo M, Lee T, Au DH, Fitzgibbon M. Underutilization Of Spirometry In COPD: A Survey Of Primary Care Physicians. Poster session presented at: American Thoracic Society Annual International Conference; 2013 May 21; Philadelphia, PA.
  86. Au DH. Comparative Effectiveness Research In COPD. Paper presented at: American Thoracic Society Annual International Conference; 2013 May 20; Philadelphia, PA.
  87. Au DH. What's Missing From the COPD Guidelines And Why? Vaccination, Smoking Cessation, Comorbidities And End Of Life Care Planning. Paper presented at: American Thoracic Society Annual International Conference; 2013 May 20; Philadelphia, PA.
  88. Au DH. Would The National Quality Forum (NQF) Endorse A Measure For COPD Self-Management? Paper presented at: American Thoracic Society Annual International Conference; 2013 May 19; Philadelphia, PA.
  89. Fan VS. A Disease Management Program For COPD: Disparate Results From Two Multicenter VA Studies On Disease Management In COPD. Paper presented at: American Thoracic Society Annual International Conference; 2013 May 19; Philadelphia, PA.
  90. Cecere-Feemster LM, Parsons E, Crothers K, Plumely R, Collins M, Moss B, Udris EM, Au DH, Ackerman RT. The Association Of Body Mass Index With ICU Admission and Mechanical Ventilation Among Veterans Hospitalized With An Exacerbation Of COPD. Poster session presented at: American Thoracic Society Annual International Conference; 2013 May 17; Philadelphia, PA.
  91. Fan VS. VA Research Management of COPD. Paper presented at: American Thoracic Society Annual International Conference; 2013 May 17; Philadelphia, PA.
  92. Nguyen H, Herting J, Adams S, Borson S, Kohen R, Matute-Bello G, Pagalilauan G, Fan VS. Identifying Latent Symptom Classes In Patients With Advanced COPD. Poster session presented at: American Thoracic Society Annual International Conference; 2013 May 17; Philadelphia, PA.
  93. Parsons E, Cecere-Feemster LM, Plumley R, Collins M, Moss B, Udris EM, Au DH, Ackerman RT. Association Of Corticosteroid Dose With Antipsychotic Use, Delirium, And Length Of Stay Among Veterans Hospitalized For COPD Exacerbation. Poster session presented at: American Thoracic Society Annual International Conference; 2013 May 17; Philadelphia, PA.
  94. Pickard A, Lee T, Lin F, Au DH, McBurnie M, Carson S, Lindenauer P, Mularski R, Naureckas E, Vollmer W, Henderson A, Krishnan J. Assessment Of Health-Related Quality Of Life Using EQ-5D-5L In Patients With Chronic Obstructive Pulmonary Disease (COPD): Experience In The CONCERT Cohort. Poster session presented at: American Thoracic Society Annual International Conference; 2013 May 17; Philadelphia, PA.
  95. Prieto-Centurion V, Rolle A, Au DH, Carson S, Henderson A, Lee T, Lindenauer P, McBurnie M, Mularski R, Naureckas E, Vollmer W, Krishnan J. A Comparison Of Three Methods Used To Identify Patients With COPD. Poster session presented at: American Thoracic Society Annual International Conference; 2013 May 17; Philadelphia, PA.
  96. Katz DF, Schneider PM, Pelligrini CN, Heidenreich PA, Aleong RG, Keung EC, Massie BM, Varosy PD. Prevalent COPD and Subsequent Mortality Among Veterans Undergoing ICD Implantation. Poster session presented at: Heart Rhythm Society Annual Scientific Sessions; 2013 May 10; Denver, CO.
  97. Herrin MA, Feemster LC, Crothers K, Uman JE, Bryson CL, Au DH. Combination antihypertensive therapy among patients with COPD. Chest. 2013 May 1; 143(5):1312-20.
  98. Huetsch JC, Uman JE, Udris EM, Au DH. Erratum to: Predictors of Adherence to Inhaled Medications among Veterans with COPD. Journal of general internal medicine. 2013 May 1; 28(5):743-7.
  99. Melzer AC, Feemster LM, Uman JE, Ramenofsky DH, Au DH. Missing potential opportunities to reduce repeat COPD exacerbations. Journal of general internal medicine. 2013 May 1; 28(5):652-9.
  100. Park SK, Richardson CR, Holleman RG, Larson JL. Frailty in people with COPD, using the National Health and Nutrition Evaluation Survey dataset (2003-2006). Heart & lung : the journal of critical care. 2013 May 1; 42(3):163-70.
  101. Siddique HH, Olson RH, Parenti CM, Rector TS, Caldwell M, Dewan NA, Rice KL. Randomized trial of pragmatic education for low-risk COPD patients: impact on hospitalizations and emergency department visits. International journal of chronic obstructive pulmonary disease. 2013 Apr 23; 7:719-28.
  102. Regan EA, Radcliff TA, Henderson WG, Cowper Ripley DC, Maciejewski ML, Vogel WB, Hutt E. Improving hip fractures outcomes for COPD patients. COPD. 2013 Feb 1; 10(1):11-9.
  103. Kunz R, Fretheim A, Cluzeau F, Wilt TJ, Qaseem A, Lelgemann M, Kelson M, Guyatt G, Schünemann HJ, ATS/ERS Ad Hoc Committee on Integrating and Coordinating Efforts in COPD Guideline Development. Guideline group composition and group processes: article 3 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report. Proceedings of the American Thoracic Society. 2012 Dec 1; 9(5):229-33.
  104. Wilt TJ, Guyatt G, Kunz R, Macnee W, Puhan MA, Viegi G, Woodhead M, Akl EA, Schünemann HJ, ATS/ERS Ad Hoc Committee on Integrating and Coordinating Efforts in COPD Guideline Development. Deciding what type of evidence and outcomes to include in guidelines: article 5 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report. Proceedings of the American Thoracic Society. 2012 Dec 1; 9(5):243-50.
  105. Huetsch JC, Uman JE, Udris EM, Au DH. Predictors of adherence to inhaled medications among Veterans with COPD. Journal of general internal medicine. 2012 Nov 1; 27(11):1506-12.
  106. Collins EG, Halabi S, Langston M, Schnell T, Tobin MJ, Laghi F. Sexual dysfunction in men with COPD: impact on quality of life and survival. Lung. 2012 Oct 1; 190(5):545-56.
  107. Covey MK, McAuley E, Kapella MC, Collins EG, Alex CG, Berbaum ML, Larson JL. Upper-Body Resistance Training and Self-Efficacy Enhancement in COPD. Journal of Pulmonary and Respiratory Medicine. 2012 Sep 1;(9):1-8.
  108. Moy ML, Weston NA, Wilson EJ, Hess ML, Richardson CR. A pilot study of an Internet walking program and pedometer in COPD. Respiratory medicine. 2012 Sep 1; 106(9):1342-50.
  109. Leung JM, Udris EM, Uman J, Au DH. The effect of end-of-life discussions on perceived quality of care and health status among patients with COPD. Chest. 2012 Jul 1; 142(1):128-33.
  110. Cecere LM, Slatore CG, Uman JE, Evans LE, Udris EM, Bryson CL, Au DH. Adherence to long-acting inhaled therapies among patients with chronic obstructive pulmonary disease (COPD). COPD. 2012 Jun 1; 9(3):251-8.
  111. Moy ML, Weston NA, Wilson EJ, Richardson CR. An Internet-Mediated Program and Pedometer Increase Walking in COPD. Poster session presented at: American Thoracic Society Annual International Conference; 2012 May 22; San Francisco, CA.
  112. Fan VS, Nguyen HQ, Adams S, Borson S, Herting J, Kohen R, Matute-Bello G. Depression is Not Associated with Six Minute Walk Performance with COPD. Poster session presented at: American Thoracic Society Annual International Conference; 2012 May 21; San Francisco, CA.
  113. Sibila O, Mortensen EM, Anzueto A, Laserna E, Restrepo MI. Prior cardiovascular disease is associated with increased short and long-term mortality in COPD patients with community-acquired pneumonia. Poster session presented at: American Thoracic Society Annual International Conference; 2012 May 18; San Francisco, CA.
  114. Mignogna J, Cully J. Depression and Anxiety in Patients with COPD: A Focus on Psychological Treatments in Ambulatory Care Settings. Current respiratory medicine reviews. 2012 Apr 1; 8(2):137-144(8).
  115. Moinuddin IK, Collins EG, Kramer HJ, Leehey DJ. Upper-Body Resistance Training and Self-Efficacy Enhancement in COPD. Journal of obesity & weight loss therapy. 2012 Mar 9; 2(2):1-12.
  116. Sautter J, Tulsky JA, Steinhauser KE. Anticipatory grief among family caregivers of patients with advanced cancer, CHF, and COPD. Poster session presented at: American Academy of Hospice and Palliative Medicine Annual Assembly; 2012 Mar 7; Denver, CO.
  117. Au DH, Udris EM, Engelberg RA, Diehr PH, Bryson CL, Reinke LF, Curtis JR. A randomized trial to improve communication about end-of-life care among patients with COPD. Chest. 2012 Mar 1; 141(3):726-35.
  118. Nici L, ZuWallack R, American Thoracic Society Subcommittee on Integrated Care of the COPD Patient. An official American Thoracic Society workshop report: the Integrated Care of The COPD Patient. Proceedings of the American Thoracic Society. 2012 Mar 1; 9(1):9-18.
  119. Stein BD, Bautista A, Schumock GT, Lee TA, Charbeneau JT, Lauderdale DS, Naureckas ET, Meltzer DO, Krishnan JA. The validity of International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis codes for identifying patients hospitalized for COPD exacerbations. Chest. 2012 Jan 1; 141(1):87-93.
  120. Joo MJ, Au DH, Fitzgibbon ML, McKell J, Lee TA. Determinants of spirometry use and accuracy of COPD diagnosis in primary care. Journal of general internal medicine. 2011 Nov 1; 26(11):1272-7.
  121. Halabi S, Collins EG, Thorevska N, Tobin MJ, Laghi F. Relationship between depressive symptoms and hypogonadism in men with COPD. COPD. 2011 Oct 1; 8(5):346-53.
  122. Cecere LM, Littman AJ, Slatore CG, Udris EM, Bryson CL, Boyko EJ, Pierson DJ, Au DH. Obesity and COPD: associated symptoms, health-related quality of life, and medication use. COPD. 2011 Aug 2; 8(4):275-84.
  123. Chen D, Restrepo MI, Fine MJ, Pugh MJ, Anzueto A, Metersky ML, Nakashima B, Good C, Mortensen EM. Observational study of inhaled corticosteroids on outcomes for COPD patients with pneumonia. American journal of respiratory and critical care medicine. 2011 Aug 1; 184(3):312-6.
  124. Janssen DJ, Curtis JR, Au DH, Spruit MA, Downey L, Schols JM, Wouters EF, Engelberg RA. Patient-clinician communication about end-of-life care for Dutch and US patients with COPD. European Respiratory Journal. 2011 Aug 1; 38(2):268-76.
  125. Sautter J, Burton A, Tulsky JA, Olsen MK, Lindquist JH, Hays JC, Zimmerman S, Steinhauser KE. Burden and Well-being among a diverse sample of cancer, CHF, and COPD caregivers. Poster session presented at: National Institute of Nursing Research Scientific Symposium; 2011 Jul 6; Bethesda, MD.
  126. Restrepo MI, Mortensen EM, Anzueto A. Are COPD patients with pneumonia who are taking inhaled corticosteroids at higher risk of dying? European Respiratory Journal. 2011 Jul 1; 38(1):1-3.
  127. Sautter J. Are there racial patterns in family caregiving burden for patients with cancer, COPD, or CHF? (Top Poster). Poster session presented at: National Research Service Award Trainees Annual Conference; 2011 Jun 11; Seattle, WA.
  128. Cecere LM, Slatore CG, Uman JE, Evans LE, Udris EM, Bryson CL, Au DH. Factors Associated with Adherence to Long-Acting Inhaled Therapies Among Patients with COPD. Presented at: American Thoracic Society Annual International Conference; 2011 May 15; Denver, CO.
  129. Greene CC, Williams EC, Bradley KA, Au DH. The Association between Alcohol Misuse and Health Status among Veterans with COPD. Poster session presented at: American Thoracic Society Annual International Conference; 2011 May 15; Denver, CO.
  130. Hussain O, Collins EG, Adiguzel N, Langbein WE, Tobin MJ, Laghi F. Contrasting pressure-support ventilation and helium-oxygen during exercise in severe COPD. Respiratory medicine. 2011 Mar 1; 105(3):494-505.
  131. Cuttica MJ, Kalhan R, Shlobin OA, Ahmad S, Gladwin M, Machado RF, Barnett SD, Nathan SD. Categorization and impact of pulmonary hypertension in patients with advanced COPD. Respiratory medicine. 2010 Dec 1; 104(12):1877-82.
  132. Bossi KE. HSR&D ePub Briefs-1, Nov 2010, PTSD, HTN, Diabetes, Prostate Cancer, OEF/OIF, COPD. 2010 Nov 23; 3(1).
  133. Slatore CG, Cecere LM, Reinke LF, Ganzini L, Udris EM, Moss BR, Bryson CL, Curtis JR, Au DH. Patient-clinician communication: associations with important health outcomes among veterans with COPD. Chest. 2010 Sep 1; 138(3):628-34.
  134. Wilke CT, Lin FJ, Lee TA, Lambert BL, Joo MJ, Pickard AS. Variability in measurement of medication exposure in pharmacoepidemiology studies of COPD. Paper presented at: Pharmacoepidemiology and Therapeutic Risk Management Annual International Conference; 2010 Aug 1; Brighton, England.
  135. Steele BG, Dougherty CM, Hunziker J, Gylys-Colwell I. Validity and Reliability of the Stepwatch (Orthocare Innovations) in Monitoring Everyday Physical Activity in Severe COPD. Poster session presented at: American Thoracic Society Annual International Conference; 2010 May 17; New Orleans, LA.
  136. Au DH, Krishnan JA, Lee TA, Mularski RA, Carson SS, Vollmer WM, McBurnie MA, Udris EM, Cecere LM, Lindenauer P. Variation in treatment of patients with COPD exacerbations. Presented at: American Thoracic Society Annual International Conference; 2010 May 15; New Orleans, LA.
  137. Greene CC, Udris EM, Au DH. The Effect of a Diagnosis of COPD and/or OSA on Statin Adherence in a Cohort of US Veterans. Presented at: American Thoracic Society Annual International Conference; 2010 May 15; New Orleans, LA.
  138. Huetsch JC, Udris EM, Au DH. Predictors of Adherence to Inhaled Medications in Patients with COPD. Presented at: American Thoracic Society Annual International Conference; 2010 May 15; New Orleans, LA.
  139. Joo MJ, Au DH, Fitzgibbon M, Lee TA. Determinants of Spirometry Use and Accuracy of COPD in Primary Care. Presented at: American Thoracic Society Annual International Conference; 2010 May 15; New Orleans, LA.
  140. Reinke LF, Udris EM, Moss BS, Johnson EA, Slatore CG, Au DH. The Association of Depression and Preferences for Life-Sustaining Treatments in Veterans with COPD. Presented at: American Thoracic Society Annual International Conference; 2010 May 15; New Orleans, LA.
  141. Cully J. Improving depression and anxiety symptoms (in COPD) using Cognitive Behavioral Therapy. Poster session presented at: American Thoracic Society Annual International Conference; 2010 May 14; New Orleans, LA.
  142. Sharafkhaneh A, Petersen NJ, Yu HJ, Dalal AA, Johnson ML, Hanania NA. Burden of COPD in a government health care system: a retrospective observational study using data from the US Veterans Affairs population. International journal of chronic obstructive pulmonary disease. 2010 May 6; 5:125-32.
  143. Lee TA, Joo MJ, Krishnan JA, Wilke CT, Schumock GT, Pickard AS. Risk of Stroke Associated with Ipratropium and Tiotropium Use in Patients with COPD. Paper presented at: American Thoracic Society Annual International Conference; 2010 May 1; New Orleans, LA.
  144. Stein BD, Bautista A, Charbeneau JT, Schumock GT, Lee TA. Validity of ICD-9 code algorithms for identifying patients hospitalized for acute exacerbation of COPD. Paper presented at: American Thoracic Society Annual International Conference; 2010 May 1; New Orleans, LA.
  145. Steinhauser KE, Olsen MK, Tulsky JA. Quality of life and functional status and emotional well being of patients with cancer, CHF, and COPD: Does diagnosis matter or is sick, sick? Paper presented at: European Association for Palliative Care Research Annual Forum; 2010 May 1; Risor, Norway.
  146. Omachi TA, Katz PP, Yelin EH, Iribarren C, Knight SJ, Blanc PD, Eisner MD. The COPD Helplessness Index: a new tool to measure factors affecting patient self-management. Chest. 2010 Apr 1; 137(4):823-30.
  147. Nguyen HQ, Gill DP, Wolpin S, Steele BG, Benditt JO. Pilot study of a cell phone-based exercise persistence intervention post-rehabilitation for COPD. International journal of chronic obstructive pulmonary disease. 2010 Feb 4; 4:301-13.
  148. Joo MJ, Au DH, Fitzgibbon ML, Lee TA. Inhaled corticosteroids and risk of pneumonia in newly diagnosed COPD. Respiratory medicine. 2010 Feb 1; 104(2):246-52.
  149. Ogale SS, Lee TA, Au DH, Boudreau DM, Sullivan SD. Cardiovascular events associated with ipratropium bromide in COPD. Chest. 2010 Jan 1; 137(1):13-9.
  150. Lee TA, Pickard AS, Au D, Bartle B, Weiss KB. Medication Safety in COPD Patients: The Risk of Mortality Associated with Treatment in Veterans with Newly Diagnosed COPD. Paper presented at: American College of Chest Physicians Annual International Scientific Assembly (CHEST); 2009 Oct 28; Philadelphia, PA.
  151. Nielsen R, Johannessen A, Benediktsdottir B, Gislason T, Buist AS, Gulsvik A, Sullivan SD, Lee TA. Present and future costs of COPD in Iceland and Norway: results from the BOLD study. European Respiratory Journal. 2009 Oct 1; 34(4):850-7.
  152. Cecere LM, Udris EM, Slatore C, Bryson CL, Au DH. The Effect of Obesity on Symptoms of Dyspnea, Health-Related Quality of Life, and Medication Use in Veterans with COPD. [Abstract]. American journal of respiratory and critical care medicine. 2009 Jun 15; 179:A2916.
  153. Mortensen EM, Copeland LA, Pugh MJ, Restrepo MI, de Molina RM, Nakashima B, Anzueto A. Impact of statins and ACE inhibitors on mortality after COPD exacerbations. Respiratory Research. 2009 Jun 3; 10:45.
  154. Cooke CR, Joo M, Udris EM, Johnson E, Au DH. Using Administrative Data to Accurately Identify Patients with Chronic Obstructive Pulmonary Disease (COPD). Poster session presented at: American Thoracic Society Annual International Conference; 2009 May 19; San Diego, CA.
  155. Au DH, Udris EM, Diehr PK, Engelberg RA, Curtis JR. A Randomized Trial to Improve the Occurrence and Quality of Communication about End-of-Life Care among Patients with COPD - Mini Symposium. Presented at: American Thoracic Society Annual International Conference; 2009 May 18; San Diego, CA.
  156. Cecere LM, Udris EM, Slatore C, Bryson CL, Au DH. The Effect of Obesity on Symptoms of Dyspnea, Health-related Quality of Life, and Medication Use in Veterans with COPD. Poster session presented at: American Thoracic Society Annual International Conference; 2009 May 18; San Diego, CA.
  157. Coppersmtih J, Gylys-Colwell MA, Dougherty CM, Schneider MN, Hunziker MN, Short V, Sablinsky M, Steele BG. Combined Rehabilitation Program for Chronic Obstructive Pulmonary Disease (COPD) and Heart Failure (HF). Presented at: American Thoracic Society Annual International Conference; 2009 May 17; San Diego, CA.
  158. Fan VS, Udris EM, Au DH. Factors Associated with Efficacy in COPD. Poster session presented at: American Thoracic Society Annual International Conference; 2009 May 17; San Diego, CA.
  159. Nguyen HQ, Burr R, Wolpin S, Steele BG. How many physical activity monitoring days are optimal for patients with COPD? Proceedings of the American Thoracic Society. Presented at: American Thoracic Society Annual International Conference; 2009 May 17; San Diego, CA.
  160. Nguyen HQ, Fan VS, Reinke LF, Kohen R, Borson S. Association between Depression, Exercise Performance, Self-Reported Physical Functioning, and Free-Living Ambulatory Activity in Severe COPD. Poster session presented at: American Thoracic Society Annual International Conference; 2009 May 17; San Diego, CA.
  161. Malo de Molina R, Mortensen EM, Restrepo MI, Copeland LA, Pugh MV, Anzueto A. Outpatient Inhaled Corticosteroid (ICS) therapy decreases mortality in patients with Chronic Obstructive Pulmonary Disease (COPD) and pneumonia. Paper presented at: American Thoracic Society Annual International Conference; 2009 May 15; San Diego, CA.
  162. Mortensen EM, Copeland LA, Pugh MV, Malo de Molina R, Restrepo MI, Anzueto A. Impact of prior statin and ACE inhibitor use on mortality for subjects hospitalized with COPD exacerbations. Paper presented at: American Thoracic Society Annual International Conference; 2009 May 15; San Diego, CA.
  163. Lee TA. Challenges and opportunities to improving COPD care in complex medical patients. Paper presented at: American Thoracic Society Annual International Conference; 2009 May 1; San Diego, CA.
  164. Lee TA. Epidemiology of multiple chronic conditions in elderly patients with COPD. Paper presented at: American Thoracic Society Annual International Conference; 2009 May 1; San Diego, CA.
  165. Lee TA, Wilke CT, Joo M, Stroupe KT, Krishnan JA, Schumock GT, Pickard AS. Comparative effectiveness of ipratropium in COPD patients. Paper presented at: International Society for Pharmacoeconomics and Outcomes Research Annual European Congress; 2009 May 1; Orlando, FL.
  166. Lee TA, Wilke CT, Joo M, Stroupe KT, Krishnan JA, Schumock GT, Pickard AS. Outcomes associated with tiotropium use in COPD patients. Paper presented at: International Society for Pharmacoeconomics and Outcomes Research Annual Meeting; 2009 May 1; Orlando, FL.
  167. Stein BD, Bautista A, Schumock GT, Lee TA, Meltzer DO, Naureckas ET, Krishnan JA. Specificity of ICD-9 diagnosis codes for identifying patients hospitalized for COPD. Paper presented at: American Thoracic Society Annual International Conference; 2009 May 1; San Diego, CA.
  168. Jung E, Pickard AS, Salmon JW, Bartle B, Lee TA. Medication adherence and persistence in the last year of life in COPD patients. Respiratory medicine. 2009 Apr 1; 103(4):525-34.
  169. Jordan N, Lee TA, Valenstein M, Pirraglia PA, Weiss KB. Effect of depression care on outcomes in COPD patients with depression. Chest. 2009 Mar 1; 135(3):626-32.
  170. Au DH, Udris EM, Diehr P, Engelberg RA, Curtis JR. A Randomized Trial to Improve the Occurrence and Quality of Communication about End-of-Life Care among Patients with COPD. Poster session presented at: VA HSR&D National Meeting; 2009 Feb 13; Washington, DC.
  171. Rice KL, Dewan N, Niewoehner DE, Bloomfield HE, Grill J, Schult TM, Nelson DB, Kumari S, Thomas M, Geist LJ. Case/Self-Management in COPD: A Randomized Trial. Paper presented at: VA HSR&D National Meeting; 2009 Feb 12; Baltimore, MD.
  172. Pickard AS, Jung E, Bartle B, Weiss KB, Lee TA. Coded cause of death and timing of COPD diagnosis. COPD. 2009 Feb 1; 6(1):41-7.
  173. Joo MJ, Lee TA, Au DH, Fitzgibbon ML, Weiss KB. Medication use patterns associated with spirometry in diagnosing COPD. COPD. 2008 Dec 1; 5(6):360-8.
  174. Foreman MG, DeMeo DL, Hersh CP, Carey VJ, Fan VS, Reilly JJ, Shapiro SD, Silverman EK. Polymorphic variation in surfactant protein B is associated with COPD exacerbations. European Respiratory Journal. 2008 Oct 1; 32(4):938-44.
  175. Greene CC, Bradley KA, Bryson CL, Blough DK, Evans LE, Udris EM, Au DH. The association between alcohol consumption and risk of COPD exacerbation in a veteran population. Chest. 2008 Oct 1; 134(4):761-7.
  176. Maurer J, Rebbapragada V, Borson S, Goldstein R, Kunik ME, Yohannes AM, Hanania NA, ACCP Workshop Panel on Anxiety and Depression in COPD. Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest. 2008 Oct 1; 134(4 Suppl):43S-56S.
  177. Joo MJ, Lee TA, Bartle B, van de Graaff WB, Weiss KB. Patterns of healthcare utilization by COPD severity: a pilot study. Lung. 2008 Sep 1; 186(5):307-12.
  178. Joo MJ, Lee TA, Weiss KB. Geographic variation of spirometry use in newly diagnosed COPD. Chest. 2008 Jul 1; 134(1):38-45.
  179. Rice KL, Dewan N, Bloomfield HE, Grill J, Schult TE, Nelson DB, Kumari S, Thomas M, Geist LJ, Beaner C, Caldwell M, Niewoehner DE. Self Management for COPD: A Randomized Controlled Trial. Presented at: American Thoracic Society Annual International Conference; 2008 May 21; Toronto, Canada.
  180. Foreman MG, DeMeo DL, Hersh CP, Reiilly JJ, Carey VJ, Litonjus AA, Fan VS, Shapiro SD, Silverman EK, Schultz EM, Gould MK. Variants in Surfactant Protein D are Associated with Susceptibility to COPD. Poster session presented at: American Thoracic Society Annual International Conference; 2008 May 17; Toronto, Canada.
  181. Foreman MG, DeMeo DL, Hersh CP, Reilly JJ, Carey VJ, Fan VS, Shapiro SD, Silverman EK. Polymorphisms in Innate Immunity Genes are Associated with COPD Exacerbations. Poster session presented at: American Thoracic Society Annual International Conference; 2008 May 17; Toronto, Canada.
  182. Steele BG, Cain K, Belza B, Coppersmith JR, Howard PJ, Lakshiminarayan PS. Pulmonary Rehabilitation (PR) Outcomes in Chronic Obstructive Pulmonary Disease (COPD) - Are Benefits Equivalent in End-Stage Disease? Paper presented at: American Thoracic Society Annual International Conference; 2008 May 17; Toronto, Canada.
  183. Steele BG, Cain K, Coppersmith J, Belza B, Howard J, Lakshminarayan S. Pulmonary rehabilitation (PR) outcomes in chronic obstructive pulmonary disease (COPD): Are benefits equivalent in end-stage disease? Proceedings of the American Thoracic Society. 2008 May 17; 177:A446.
  184. Cannon KT, Sarrain MV, Kaldjian LC, Rosenthal GE. Racial differences in hospital mortality among older veterans with COPD are not explained by differences in ICU admission or use of ventilatory support. Presented at: American Geriatrics Society Annual Meeting; 2008 May 1; Washington, DC.
  185. Lee TA, Pickard AS, Bartle B, Weiss KB. COPD medication safety: risk of respiratory and cardiovascular deaths associated with treatment. Poster session presented at: American Thoracic Society Annual International Conference; 2008 May 1; Toronto, Canada.
  186. Lee TA, Tan W, Fitzgerald M, Sin D, Marra C, Weiss KB, Sullivan SD. Future economic burden of COPD in Canada: Results from the BOLD Initiative. Poster session presented at: American Thoracic Society Annual International Conference; 2008 May 1; Toronto, Canada.
  187. Cannon, Sarrazin, Kaldjian LC, Rosenthal. Racial differences in hospital mortality among veterans with COPD are not explained by differences in ICU admission or use of ventilatory support. Poster session presented at: VA HSR&D National Meeting; 2008 Apr 10; Baltimore, MD.
  188. Au DH. Use of beta blockers in patients with COPD. Thorax. 2008 Apr 1; 63(4):296-8.
  189. Wilke C, Pickard AS, Jung E, Patel S, Stavem K, Lee TA. Use of a preference-based measure of health (EQ-5D) in COPD and asthma. Respiratory medicine. 2008 Apr 1; 102(4):519-36.
  190. Kunik ME, Veazey C, Cully JA, Souchek J, Graham DP, Hopko D, Carter R, Sharafkhaneh A, Goepfert EJ, Wray N, Stanley MA. COPD education and cognitive behavioral therapy group treatment for clinically significant symptoms of depression and anxiety in COPD patients: a randomized controlled trial. Psychological medicine. 2008 Mar 1; 38(3):385-96.
  191. Lee TA, Ogale SS, Sulivan SD, Au D. Risk of All-Cause Mortality Associated with Long-Acting Beta-Agonist Use in Veterans with COPD. Paper presented at: VA HSR&D National Meeting; 2008 Feb 15; Baltimore, MD.
  192. Lee TA, Pickard AS, Bartle B, Weiss KB. Medication Safety in COPD Patients: The Risk of Respiratory and Cardiovascular Deaths Associated with Treatment in Veterans with COPD. Paper presented at: VA HSR&D National Meeting; 2008 Feb 14; Baltimore, MD.
  193. McGhan R, Radcliff T, Fish R, Sutherland ER, Welsh C, Make B. Predictors of rehospitalization and death after a severe exacerbation of COPD. Chest. 2007 Dec 1; 132(6):1748-55.
  194. Au DH, Curtis JR. Providing Palliative and End of Life Care for Patients with COPD. In: Lung Biology in Health and Disease. New York, NY: Informa Healthcare, USA 2nd Edition; 2007. 515-530 p.
  195. Jordan N, Lee TA, Valenstein M, Weiss KB. Effect of care setting on evidence-based depression treatment for veterans with COPD and comorbid depression. Journal of general internal medicine. 2007 Oct 1; 22(10):1447-52.
  196. Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, Menezes AM, Sullivan SD, Lee TA, Weiss KB, Jensen RL, Marks GB, Gulsvik A, Nizankowska-Mogilnicka E, BOLD Collaborative Research Group. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. 2007 Sep 1; 370(9589):741-50.
  197. Wilt TJ, MacNee W, Guyatt G, Viegi G, Woodhead M, Kunz R, Schunemann H, Puhan M. Integrating and Coordinating Efforts in Chronic Obstructive Pulmonary Disease (COPD): Deciding what kind of evidence to include in guidelines. Paper presented at: American Thoracic Society Annual International Conference; 2007 Jun 1; Washington, DC.
  198. Gould MK. Are there cost-effective therapies in COPD? Presented at: American Thoracic Society Annual International Conference; 2007 May 23; San Francisco, CA.
  199. Au DH. Defining COPD, time for a new paradigm? Paper presented at: American Thoracic Society Annual International Conference; 2007 May 22; San Francisco, CA.
  200. Cecere LM, Bryson CL, Evans LE, Udris EM, Au DH. Hazardous drinking and health related behaviors among patients with COPD. Paper presented at: American Thoracic Society Annual International Conference; 2007 May 22; San Francisco, CA.
  201. Adams SG, Simpson T, Lee S, Vipraio G, Anzueto A, Pugh JA, Allan PF. Unrecognized depression is common and associated with worse functional status in high-risk COPD patients. Paper presented at: American Thoracic Society Annual International Conference; 2007 May 20; San Francisco, CA.
  202. Allan PF, Abouchahine S, Lee S, Smith PK, Pugh JA, Anzueto A, Adams SG. Anxiety and depression are associated with frequent acute exacerbations of COPD in high-risk COPD population. Presented at: American Thoracic Society Annual International Conference; 2007 May 20; San Francisco, CA.
  203. Cannon KC, Rosenthal GE, Vaughan Sarrazin MS, Kaldjian LS, Curtis AE. Racial differences in treatment of COPD exacerbation in older veterans. Poster session presented at: American Geriatrics Society Annual Meeting; 2007 May 3; Seattle, WA.
  204. Lee TA, Gislason T, Sullivan SD, Benediktsdottir B, Gudmundsson G, Buist AS, Weiss KB. Future economic burden of COPD in Iceland: results from the BOLD initiative. Poster session presented at: American Thoracic Society Annual International Conference; 2007 May 1; San Francisco, CA.
  205. Lee TA, Pickard AS, Bartle B, Schmock GT, Weiss KB. Increased risk of mortality associated with use of ipratropium and theophylline in COPD patients. Poster session presented at: American Thoracic Society Annual International Conference; 2007 May 1; San Francisco, CA.
  206. Ogale SS, Lee TA, Au DH, Boudreau DM, Sullivan SD. Long-acting beta2-agonists and all-cause mortality in COPD. Poster session presented at: American Thoracic Society Annual International Conference; 2007 May 1; San Francisco, CA.
  207. Mortensen EM, Leykum L, Noel PH, Zeber JE, Pugh MJ, Lawrence VA. Organizational interventions to improve outcomes for patients with COPD. Poster session presented at: Society of General Internal Medicine Annual Meeting; 2007 Apr 26; Toronto, Canada.
  208. Fan VS, Ramsey SD, Make BJ, Martinez FJ. Physiologic variables and functional status independently predict COPD hospitalizations and emergency department visits in patients with severe COPD. COPD. 2007 Mar 1; 4(1):29-39.
  209. Cannon KT, Vaughan Sarrazin MS, Kaldjian LC, Rosenthal GE. Racial differences in treatment of COPD exacerbation within the VA healthcare system. Poster session presented at: VA HSR&D National Meeting; 2007 Feb 22; Washington, DC.
  210. Jordan N, Lee TA, Valenstein M, Weiss KB. Predictors of Evidence-Based Depression Treatment in Veterans with COPD and Co-Morbid Depression. Poster session presented at: VA HSR&D National Meeting; 2007 Feb 22; Arlington, VA.
  211. Cully JA, Graham DP, Stanley MA, Kunik ME. Depressed and Anxious COPD Patients: Predictors of Psychotherapy Engagement from a Clinical Trial. Journal of Clinical Psychology in Medical Settings. 2007 Jan 1; 14:160-164.
  212. Lee TA, Weaver FM, Weiss KB. Impact of Pneumococcal Vaccination on Pneumonia Rates in Patients with COPD and Asthma. Journal of general internal medicine. 2007 Jan 1; 22(1):62-7.
  213. Cannon, Sarrazin, Kaldjian LC, Curtis, Rosenthal. Racial differences in treatment of COPD exacerbation within the VA Health Care System. Poster session presented at: Institute for Healthcare Improvement on Quality Improvement in Health Care National Forum; 2006 Dec 11; Orlando, FL.
  214. Kunik ME, Veazey C, Cully JA, Souchek, Graham DP, Hopko D, Carter R, Sharafkhaneh A, Goepfert EJ, Wray NP, Stanley MA. Education vs. CBT for depression and anxiety in COPD patients. Paper presented at: Gerontological Society of America Annual Scientific Meeting; 2006 Nov 16; Dallas, TX.
  215. Adams SG, Anzueto A, Pugh JA, Lee S, Hazuda HP. Mexican American elders have similar severities of COPD despite less tobacco exposure than European American elders. Respiratory medicine. 2006 Nov 1; 100(11):1966-72.
  216. Adams, Simpson, Kearney, Lee, Vipraio, Smith , Anzueto, Pugh , Alan. Cognitive behavior group therapy improves quality of life more than general health education for anxiety in severe COPD. Poster session presented at: American College of Chest Physicians Annual International Scientific Assembly (CHEST); 2006 Oct 20; Salt Lake City, UT.
  217. Lee TA, Gao CY, Walter B, O'Connor GT, Sullivan SD, Buist AS, Weiss KB. Rate of disease progression in patients with COPD in the Framingham Heart Study cohort. Paper presented at: American College of Chest Physicians Annual International Scientific Assembly (CHEST); 2006 Oct 1; Salt Lake City, UT.
  218. Lee TA, Sin DD, Sullivan SD. Cost-effectiveness of inhaled corticosteroids in COPD: results from the BOLD economic model using ISEEC results. Poster session presented at: American College of Chest Physicians Annual International Scientific Assembly (CHEST); 2006 Oct 1; Salt Lake City, UT.
  219. McCrory DC. Time to question long-term safety of routine scheduled inhaled beta-2-agonist treatment for COPD. Journal of general internal medicine. 2006 Oct 1; 21(10):1123-4.
  220. Kunik ME. Screening for anxiety and depression in COPD. Paper presented at: American College of Chest Physicians on Depression and Anxiety Complicating Chronic Lung Disease Workshop; 2006 Sep 15; Northbrook, IL.
  221. Lee TA, Weiss KB. Economic burden of COPD. Paper presented at: European Respiratory Society Annual Congress; 2006 Sep 1; Munich, Germany.
  222. Restrepo MI, Mortensen EM, Pugh JA, Anzueto A. COPD is associated with increased mortality in patients with community-acquired pneumonia. European Respiratory Journal. 2006 Aug 1; 28(2):346-51.
  223. Pickard AS, Lee TA, Bartle B, Weiss KB. Medication Use and Causes of Death in Veterans with COPD: A Large Database Study. Poster session presented at: Midwest Pharmacy Administration Annual Meeting; 2006 Jul 1; Minneapolis, MN.
  224. Lee TA, Bartle B, Weiss KB. Spirometry use in clinical practice following diagnosis of COPD. Chest. 2006 Jun 1; 129(6):1509-15.
  225. Gross RD, Atwood CW, Ross SB, Olszewski JW, Eichhorn KA, Doyle PJ. Coordination of respiratory cycle and deglutition in COPD vs. healthy controls. Poster session presented at: American Thoracic Society Annual International Conference; 2006 May 24; San Diego, CA.
  226. Adams SG, Pugh JA, Kazis LE, Lee S, Anzueto A. Characteristics associated with sustained abstinence from smoking among patients with COPD. The American journal of medicine. 2006 May 1; 119(5):441-7.
  227. Jordan N, Lee T, Valenstein M, Weiss K. Factors Associated with Evidence-Based Depression Treatment for Persons with COPD and Depression. Poster session presented at: American Thoracic Society Annual International Conference; 2006 May 1; San Diego, CA.
  228. Lee TA, Sullivan SD, Buist AS, Vollmer WB, Weiss KB. Estimating the future economic burden of COPD. Poster session presented at: American Thoracic Society Annual International Conference; 2006 May 1; San Diego, CA.
  229. Burgess A, Kunik ME, Stanley MA. Chronic obstructive pulmonary disease: assessing and treating psychological issues in patients with COPD. Geriatrics. 2005 Dec 1; 60(12):18-21.
  230. Cully JA, Graham DP, Stanley MA, Ferguson CJ, Sharafkhaneh A, Souchek J, Kunik ME. Quality of life in patients with COPD and comorbid anxiety or depression. Paper presented at: Association for Behavioral and Cognitive Therapies Annual Convention; 2005 Nov 17; Washington, DC.
  231. Adams SG. Managing COPD: acute exacerbations. Part 2. The Journal of Respiratory Diseases. 2005 Aug 1; 26(8):335-341.
  232. Ward MM, Yankey JW, Vaughn TE, BootsMiller BJ, Flach SD, Watrin S, Doebbeling BN. Provider adherence to COPD guidelines: relationship to organizational factors. Journal of evaluation in clinical practice. 2005 Aug 1; 11(4):379-87.
  233. Wilt TJ, Niewoehner DE, Kim C, Kane RL, Linabery A, Tacklind J, MacDonald R, Rutks I. Use of Spirometry for Case Finding, Diagnosis, and Management of Chronic Obstructive Pulmonary Disease (COPD). Summary, Evidence Report/Technology Assessment: Number 121. Rockville, MD: Agency for Healthcare Research and Quality; 2005 Aug 1. Report No.: 05-E017-1.
  234. Adams SG. Managing COPD: how to deal with the most common problem. Part 1. The Journal of Respiratory Diseases. 2005 Jul 1; 26(7):284-289.
  235. Bryson CL, Au DH. The effects of smoking cessation on COPD exacerbation risk. Paper presented at: American Thoracic Society Annual International Conference; 2005 May 1; San Diego, CA.
  236. Lee TA, Bartle B, Weiss KB. Characterizing COPD Exacerbation Patterns in the VA Healthcare System. Poster session presented at: American Thoracic Society Annual International Conference; 2005 May 1; San Diego, CA.
  237. Lee TA, Bartle B, Weiss KB. Health system variation in COPD exacerbation rates. Poster session presented at: American Thoracic Society Annual International Conference; 2005 May 1; San Diego, CA.
  238. Lee TA, Bartle B, Weiss KB. Patterns of respiratory medication us in a VA COPD cohort, 1999-2002. Poster session presented at: American Thoracic Society Annual International Conference; 2005 May 1; San Diego, CA.
  239. Lee TA, Bartle B, Weiss KB. Spirometry use in clinical practice in patients with COPD. Poster session presented at: American Thoracic Society Annual International Conference; 2005 May 1; San Diego, CA.
  240. Kunik ME, Roundy K, Veazey C, Souchek J, Richardson P, Wray NP, Stanley MA. Surprisingly high prevalence of anxiety and depression in older adults with COPD. Paper presented at: American Association for Geriatric Psychiatry Annual Meeting; 2005 Mar 3; San Diego, CA.
  241. Lee TA, Bartle B, Weiss KB. Characterizing COPD Exacerbation Patterns in the VA Healthcare System. Poster session presented at: VA HSR&D National Meeting; 2005 Feb 1; Baltimore, MD.
  242. Adams SG. Acute exacerbations of COPD. Poster session presented at: American College of Chest Physicians Annual International Scientific Assembly (CHEST); 2004 Oct 23; Seattle, WA.
  243. Adams SG. Disease management in COPD [panel discussion]. Paper presented at: American College of Chest Physicians Annual International Scientific Assembly (CHEST); 2004 Oct 23; Seattle, WA.
  244. Curtis JR, Engelberg RA, Nielsen EL, Au DH, Patrick DL. Patient-physician communication about end-of-life care for patients with severe COPD. European Respiratory Journal. 2004 Aug 1; 24(2):200-5.
  245. Xu J, Lee TA, Witt WP, Durazo-Arvizu R. Emergency department visits among COPD patients: an example of repeat recurrent event analysis. Paper presented at: American Statistical Association Joint Statistical Annual Meeting; 2004 Aug 1; Toronto, Canada.
  246. Collins EG, Langbein WE, Fehr L, Bammert C, O'Connell S, Tobin M, Laghi F. Treadmill Versus Cycle Ergometry Testing in COPD. Paper presented at: American Thoracic Society Annual International Conference; 2004 May 1; Orlando, FL.
  247. Lee TA, Bartle B, Xu J, Davis K, Weiss KB. The risk of fractures associated with inhaled corticosteroid use in patients with COPD. Paper presented at: Chronic Obstructive Pulmonary Disease National Annual Conference; 2003 Nov 1; Washington.
  248. Lee TA, Xu J, Weiss KB. Do follow-up physician visits impact the risk of repeat emergency department visits in patients with COPD. Paper presented at: Chronic Obstructive Pulmonary Disease National Annual Conference; 2003 Nov 1; Washington.
  249. Collins EG, Fehr L, Bammert C, O'Connell S, Laghi F, Hanson K, Hagarty E, Langbein WE. Effect of ventilation-feedback training on endurance and perceived breathlessness during constant work-rate leg-cycle exercise in patients with COPD. Journal of rehabilitation research and development. 2003 Sep 1; 40(5 Suppl 2):35-44.
  250. Fan V, Bryson C, Au D, Bridevaux P, McDonell M, Fihn S. Inhaled Corticosteroids use over time and risk of death in COPD patients. Paper presented at: American Thoracic Society Annual International Conference; 2003 Jun 1; Seattle, WA.
  251. Sullivan SD, Buist AS, Weiss K. Health outcomes assessment and economic evaluation in COPD: challenges and opportunities. The European Respiratory Journal. Supplement. 2003 Jun 1; 41:1s-3s.
  252. Adams SG, Anzueto A, Pugh JA, Lichtenstein MJ, Hazuda HP. Mexican-Americans have significantly less exposure to tobacco than European Americans, despite similar severities of COPD. Poster session presented at: American Thoracic Society Annual International Conference; 2003 May 16; Seattle, WA.
  253. Sherman SE, Lanto AB, Nield M, Yano EM. Smoking Cessation Care Received by Veterans with Chronic Obstructive Pulmonary Disease (COPD). Paper presented at: Society of General Internal Medicine Annual Meeting; 2003 May 2; Vancouver, Canada.
  254. Restrepo MI, Adams SG, Jorgensen JH, Pugh JA, Anzueto A, Mortensen EM. Process of Care and Clinical Outcomes in COPD Patients with Community Acquired Pneumonia. Paper presented at: American Thoracic Society Annual International Conference; 2003 May 1; Seattle, WA.
  255. Au D, Curtis J, Bryson C, Fan V, Udris E, McDonell M, Fihn S. Antihypertensive medications and risk of mortality among patients with COPD and hypertension. American journal of respiratory and critical care medicine. 2003 Apr 1; 167:317.
  256. Bridevaux P, Au D, Fan V, McDonell M, Fihn S. Regional variations in health status among COPD patients. American journal of respiratory and critical care medicine. 2003 Feb 1; 167:238.
  257. Adams SG, Pugh JA, Kazis LE, Anzueto A. Former smokers with COPD have better mental health than active smokers. Paper presented at: American College of Chest Physicians Annual International Scientific Assembly (CHEST); 2002 Nov 1; San Diego, CA.
  258. Restrepo MI, Adams S, Jorgensen JH, Pugh JA, Anzueto A, Mortensen EM. Processes of Care (POC) in COPD Patients with Community-Acquired Pneumonia (CAP). Paper presented at: American College of Chest Physicians Annual International Scientific Assembly (CHEST); 2002 Nov 1; San Diego, CA.
  259. Restrepo MI, Mortensen EM, Jorgensen JH, Pugh JA, Anzueto A. Processes of care (POC) in COPD patients with severe community-acquired pneumonia (SCAP). Paper presented at: Infectious Diseases Society of America Annual Meeting; 2002 Oct 1; Chicago, IL.
  260. Kunik M, Densmore D. Depression and COPD. International journal of chronic obstructive pulmonary disease. 2002 Jun 1; 3(2):4-9.
  261. McCrory DC, Brown C, Gelfand SE, Bach PB. Management of acute exacerbations of COPD: a summary and appraisal of published evidence. Chest. 2001 Apr 1; 119(4):1190-209.
  262. Kim HF, Kunik ME, Molinari VA, Hillman SL, Lalani S, Orengo CA, Petersen NJ, Nahas Z, Goodnight-White S. Functional impairment in COPD patients: the impact of anxiety and depression. Psychosomatics. 2000 Nov 1; 41(6):465-71.
  263. Adams SG, Anzueto A, Peters JI, Cydulka C. The role of antibiotics for asthma and COPD exacerbations among older adults presenting to the emergency department. Presented at: American College of Chest Physicians Annual International Scientific Assembly (CHEST); 2000 Oct 25; San Francisco, CA.
  264. Adams SG, Melo J, Luther M, Anzueto A. Antibiotics are associated with lower relapse rates in outpatients with acute exacerbations of COPD. Chest. 2000 May 1; 117(5):1345-52.
  265. Steele BG, Holt L, Belza B, Ferris S, Lakshminaryan S, Buchner DM. Quantitating physical activity in COPD using a triaxial accelerometer. Chest. 2000 May 1; 117(5):1359-67.
  266. Dahm C, Curtis JR, Fan VS, Au D, McDonell M, Burman ML. Association between satisfaction with providers' explanations about COPD and patients' coping skills. Paper presented at: American Thoracic Society Annual International Conference; 2000 Feb 16; Toronto, Canada.
  267. McCrory DC, Hasselblad V. The results of a randomized controlled trial of hydrocortisone in acute exacerbation of COPD. The American journal of emergency medicine. 2000 Jan 1; 18(1):122.
  268. Steele BG, Holt L, Belza B, Ferris S, Lakshminaryan S, Buchner D. Quantifying physical activity in chronic obstructive pulmonary disease (COPD): Accelerometer and 6-minute walk. Paper presented at: American Thoracic Society Annual International Conference; 1998 Sep 15; Chicago, IL.
  269. Steele BG, Holt L, Belza B, Ferris S, Lakshminaryan S, Buchner D. Quantifying physical activity in chronic obstructive pulmonary disease (COPD): Accelerometer and six-minute walk. American journal of respiratory and critical care medicine. 1998 Sep 15; 157:A257.
  270. Schleyer AM, McDonell MB, Fihn SD. Relationship between depression and impaired functional status in chronic obstructive pulmonary disease (COPD). Paper presented at: VA HSR&D National Meeting; 1998 Feb 1; Washington, DC.
  271. Tu SP, McDonell MB, Spertus JA, Steele BG, Fihn SD. A new self-administered questionnaire to monitor health-related quality of life in patients with COPD. Ambulatory Care Quality Improvement Project (ACQUIP) Investigators. Chest. 1997 Sep 1; 112(3):614-22.

Questions about the HSR&D website? Email the Web Team.

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.